TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD
Overview
TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering CEFDINIR USP; GLYBURIDE; REPAGLINIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM.
API / Drug Master Files
TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- REPAGLINIDEActive2015-10-08
- GLYBURIDEActive2015-10-08
- RIBOFLAVIN 5'-PHOSPHATE SODIUMActive2015-10-08
- CEFDINIR USPActive2015-02-27
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.